• SENSEX
    NIFTY 50
Market

Wednesday's top brokerage calls: Bajaj Finance, Reliance Industries and more

Updated : 2021-02-24 09:12:33

Among brokerages, Credit Suisse is 'neutral' on Bajaj Finance. Macquarie has an 'underperform' call on Reliance and Nomura has a 'buy' call on RIL after the announcement on O2C reorganization of the firm. Here are the top brokerage calls for today:

 Credit Suisse on Bajaj Finance:  The brokerage maintains a 'neutral' call on the stock with a target at Rs 5,600 per share. It expects the lender's personal and SME loans to deliver a 25-30 percent compound annual growth rate.
Credit Suisse on Bajaj Finance: The brokerage maintains a 'neutral' call on the stock with a target at Rs 5,600 per share. It expects the lender's personal and SME loans to deliver a 25-30 percent compound annual growth rate.
 Macquarie on Reliance:  The brokerage maintains an 'underperform' rating on the stock with a target at Rs 1,350 per share. It added that the stock price implies flawless execution on the company's multi-pronged growth aspirations.
Macquarie on Reliance: The brokerage maintains an 'underperform' rating on the stock with a target at Rs 1,350 per share. It added that the stock price implies flawless execution on the company's multi-pronged growth aspirations.
 Nomura on Reliance:  The brokerage has a 'buy' call on the stock with a target at Rs 2,400 per share. It expects a 33 percent compound annual growth rate in the firm's earnings over FY20-23. It added that the demerger announcement should improve the outlook on stake sale in the O2C business.
Nomura on Reliance: The brokerage has a 'buy' call on the stock with a target at Rs 2,400 per share. It expects a 33 percent compound annual growth rate in the firm's earnings over FY20-23. It added that the demerger announcement should improve the outlook on stake sale in the O2C business.
 CLSA on HCL Tech:  The brokerage has a 'buy' call on the stock with a target at Rs 1,080 per share. It added that the firm has indicated deal pipeline is the strongest ever after potential QoQ acceleration in deal bookings in Q4.
CLSA on HCL Tech: The brokerage has a 'buy' call on the stock with a target at Rs 1,080 per share. It added that the firm has indicated deal pipeline is the strongest ever after potential QoQ acceleration in deal bookings in Q4.
 Nomura on India:  The brokerage pegs real GDP growth at -6.7 percent YoY in FY21 and +13.5 percent in FY22. It added that tailwinds for growth remain intact.
Nomura on India: The brokerage pegs real GDP growth at -6.7 percent YoY in FY21 and +13.5 percent in FY22. It added that tailwinds for growth remain intact.
 Morgan Stanley on Equity Strategy:  Portfolios should be positioned in domestic cyclical, rate-sensitives, midcaps and small caps, said the brokerage. It is overweight on consumer discretionary, industrials and financials.
Morgan Stanley on Equity Strategy: Portfolios should be positioned in domestic cyclical, rate-sensitives, midcaps and small caps, said the brokerage. It is overweight on consumer discretionary, industrials and financials.
 Jefferies on AMCs:  The brokerage has a 'buy' call on HDFC AMC and a 'hold' rating for Nippon AMC. It added that market cyclicality, high competition and adverse regulations are key risks in the space.
Jefferies on AMCs: The brokerage has a 'buy' call on HDFC AMC and a 'hold' rating for Nippon AMC. It added that market cyclicality, high competition and adverse regulations are key risks in the space.
 HSBC on Sun Pharma:  The brokerage has a 'buy' call on the stock with a target at Rs 700 per share. Anti-IL drug sales in the US are up 31.5 percent in 2020, implying strong demand, it added.
HSBC on Sun Pharma: The brokerage has a 'buy' call on the stock with a target at Rs 700 per share. Anti-IL drug sales in the US are up 31.5 percent in 2020, implying strong demand, it added.
 Motilal Oswal on Britannia:  The brokerage upgraded the stock to 'buy' with a target at Rs 4,120 per share. It sees immense structural opportunity in Britannia with a remarkable track record.
Motilal Oswal on Britannia: The brokerage upgraded the stock to 'buy' with a target at Rs 4,120 per share. It sees immense structural opportunity in Britannia with a remarkable track record.
Live TV

recommended for you

Ask Our Experts CNBC TV18

Advertisement